Profound Medical (PROF) Net Shares Issued and Repurchased (2023 - 2026)

Profound Medical has reported Net Shares Issued and Repurchased for 4 years, with the latest figure at $72000.0 in Q1 2026.

• On a quarterly basis, Net Shares Issued and Repurchased fell 61.56% year-over-year to $72000.0 in Q1 2026; TTM through Mar 2026 was $72000.0, a 61.56% decrease from a year earlier, with the FY2025 full-year figure at $240280.0, down 74.62% from the prior year.
• Net Shares Issued and Repurchased was $72000.0 for Q1 2026 at Profound Medical, down from $240280.0 in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $946900.0 in Q4 2024, with the low at $62465.0 in Q4 2023.
• Average Net Shares Issued and Repurchased over 4 years is $301792.2, with a median of $187316.0 recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased jumped 1415.89% in 2024, then tumbled 74.62% in 2025.
• Over 4 years, Net Shares Issued and Repurchased stood at $62465.0 in 2023, then surged by 1415.89% to $946900.0 in 2024, then sank by 74.62% to $240280.0 in 2025, then tumbled by 70.03% to $72000.0 in 2026.
• The last three Net Shares Issued and Repurchased figures came in at $72000.0 (Q1 2026), $240280.0 (Q4 2025), and $187316.0 (Q1 2025), per Business Quant data.